Bramerton Holdings

Bramerton Holdings is an investment and holding company with a strategic focus on the life sciences, technology, and financial services sectors. Operating from offices in London and New York, the firm provides growth funding and strategic support to both private and publicly listed companies. A key component of its healthcare activities is the commercialization of the COVIRAP diagnostic platform, a rapid, nucleic acid-based point-of-care technology. Developed in collaboration with researchers from the Indian Institute of Technology Kharagpur, COVIRAP is designed for the detection of COVID-19 and other infectious diseases. Bramerton Holdings serves as a commercialization partner, bridging the gap between innovative academic research and global healthcare markets.